Adult Long Coronavirus Disease 2019
Infectious Disease Clinics of North America,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 1, 2025
Language: Английский
FABP4 as a therapeutic host target controlling SARS-CoV-2 infection
Hatoon Baazim,
No information about this author
Emre Koyuncu,
No information about this author
Gürol Tuncman
No information about this author
et al.
EMBO Molecular Medicine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 22, 2025
Language: Английский
COVID-19 and persistent symptoms: implications for polycystic ovary syndrome and its management
Shanshan Zhang,
No information about this author
Yanqun Wu,
No information about this author
Richard Mprah
No information about this author
et al.
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 4, 2024
The
COVID-19
pandemic
has
left
a
profound
mark
on
global
health,
leading
to
substantial
morbidity
and
mortality
worldwide.
Beyond
the
immediate
symptoms
of
infection,
emergence
“long
COVID”,
long-term
effects
SARS-CoV-2,
become
significant
public
health
concern.
Long
COVID
is
multifaceted
condition
affecting
various
organs
systems,
including
cardiovascular,
digestive,
nervous,
endocrine
systems.
Individuals
diagnosed
with
polycystic
ovary
syndrome
(PCOS)
may
face
an
increased
risk
severe
infection.
It
crucial
comprehend
how
long
affects
PCOS
patients
devise
effective
treatment
care
strategies.
Here,
we
review
detrimental
its
reproductive
function,
inflammation,
metabolism,
cardiovascular
body
composition,
lifestyle,
mental
in
PCOS.
We
offer
recommendations
for
post-covid-19
management
PCOS,
emphasizing
necessity
comprehensive,
multidisciplinary
approach
patient
care.
Furthermore,
discuss
prospective
research
directions,
highlighting
significance
continued
investigations
clinical
trials
evaluate
approaches
ramifications
individuals
Language: Английский
FABP4 as a Therapeutic Host Target Controlling SARS-CoV2 Infection
Hatoon Baazim,
No information about this author
Emre Koyuncu,
No information about this author
Gürol Tuncman
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 12, 2024
Abstract
Host
metabolic
fitness
is
a
critical
determinant
of
infectious
disease
outcomes.
Obesity,
aging,
and
other
related
disorders
are
recognized
as
high-risk
modifiers
for
respiratory
infections,
including
coronavirus
though
the
underlying
mechanisms
remain
unknown.
Our
study
highlights
fatty
acid-binding
protein
4
(FABP4),
key
regulator
dysfunction
inflammation,
modulator
SARS-CoV-2
pathogenesis,
correlating
strongly
with
severity
in
COVID-19
patients.
We
demonstrate
that
loss
FABP4
function,
by
genetic
or
pharmacological
means,
reduces
SARS-CoV2
replication
disrupts
formation
viral
organelles
adipocytes
airway
epithelial
cells.
Importantly,
inhibitor
treatment
infected
hamsters
diminished
lung
titers,
alleviated
damage
reduced
collagen
deposition.
These
findings
highlight
therapeutic
potential
targeting
host
metabolism
limiting
mitigating
pathogenesis
infection.
Language: Английский
Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-Metabolism
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(8), P. 1650 - 1650
Published: July 24, 2024
Cardiovascular
disease
and
cancer
are
the
two
leading
causes
of
morbidity
mortality
in
world.
The
emerging
field
cardio-oncology
described
several
shared
risk
factors
that
predispose
patients
to
both
cardiovascular
cancer.
Post-acute
COVID-19
syndrome
is
a
chronic
condition
occurs
many
who
have
experienced
SARS-CoV-2
infection,
mainly
based
on
fatigue,
sedentary
lifestyle,
cramps,
breathing
difficulties,
reduced
lung
performance.
exposes
increased
visceral
adiposity,
insulin
resistance,
myosteatosis,
white
adipose
tissue
content
(surrounded
by
M1
macrophages
characterized
Th1/Th17
phenotype),
which
increases
recurrence.
In
this
review,
main
metabolic
affections
post-acute
at
low
high
cardiomyopathies
will
be
summarized.
Furthermore,
non-pharmacological
strategies
aimed
reducing
atherosclerotic
cardiac
provided,
especially
through
anti-inflammatory
nutrition
with
glycemic
index,
appropriate
physical
activity,
immune-modulating
bioactivities
able
reduce
obesity
improving
insulin-related
signaling
myocardial
metabolism.
Language: Английский